← Eichor
Study identifier: NCT07329036 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

ALSS - DPMAS and Therapeutic Plasma Exchange (TPE), Its Effect on Primary Coagulation, Inflammation and the Function of Vital Organs in ALF or ACLF

Condition: Acute Liver Failure  ·  Sponsor: Institute for Clinical and Experimental Medicine

PhaseNA
Planned participants25
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

The artificial liver support system (ALSS) in patients with acute on chronic liver failure - the use of combined molecular adsorption system with double plasma (DPMAS) and therapeutic plasma exchange (TPE), its effect on primary coagulation, inflammation and the function of vital organs.

This description comes directly from the study's public registry record.

Talk to the study team

Petr Piza, MD, MHA  ·  +420 602 225 077  ·  petr.piza@ikem.cz

Eva Kieslichova, ass. prof., MD, PhD  ·  +420 261 363 350  ·  evki@ikem.cz

Always discuss trial participation with your own doctor first.

Locations (1)

Institute for Clinical and Experimental Medicine (IKEM)Prague, CzechiaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07329036